Related Experiment Video
Updated: Jan 11, 2026

11:02
Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.6K
A Case of Immunotherapy-Induced Balanitis
Terrence Sun1, Danielle Brazel1, Aditya Sarvaria1
1Hematology and Medical Oncology, Scripps Clinic, San Diego, USA.
Cureus
|November 10, 2025
Summary
Pembrolizumab immunotherapy can cause balanitis, a rare but serious skin reaction. This case report demonstrates successful treatment with topical agents, allowing continued cancer therapy and management of side effects.
Area of Science:
- Oncology
- Dermatology
- Immunology
Background:
- Immunotherapy, particularly immune checkpoint inhibitors like pembrolizumab, is a cornerstone in cancer treatment.
- While effective, these therapies can induce a range of immune-related adverse events, including dermatologic toxicities.
- Serious skin reactions, though less common than dermatitis, necessitate careful monitoring and management.
Related Concept Videos
Sexually Transmitted Infections
892
Sexually transmitted infections (STIs) are diseases transmitted primarily through unsafe sexual interactions. Bacteria, viruses, or parasites cause them and can result in severe health complications if untreated.ChlamydiaThe bacterium Chlamydia trachomatis is responsible for the disease Chlamydia, the most common STI in the United States. This peculiar pathogen requires human cells to reproduce, residing intracellularly. The initial infection often goes unnoticed because it typically does not...
892
Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
